Long Shortz with Orthocell: Changing lives for the better around the world
Stockhead TV
share
Stockhead’s Sarah Hughan sits down with Orthocell (ASX:OCC) chair John Van Der Wielen to get the short end of the long story on the company’s latest news.
Regenerative medicine company Orthocell is further expanding the sales of its products globally, which include a nerve repair collagen wrap, and a bone and tissue repair collagen membrane.
And its Q4 2024 report out in July reported a record quarterly revenue and plenty of cash at bank.
Tune in to hear Orthocell’s John Van Der Wielen on the life-changing products, its star-studded board, and more.
This video was developed in collaboration with Orthocell, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
